Basic information Application Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Quinoline compounds >  8-BROMO-2,4-DICHLOROQUINAZOLINE

8-BROMO-2,4-DICHLOROQUINAZOLINE

Basic information Application Safety Supplier Related

8-BROMO-2,4-DICHLOROQUINAZOLINE Basic information

Product Name:
8-BROMO-2,4-DICHLOROQUINAZOLINE
Synonyms:
  • 2,4-DICHLORO-8-BROMOQUINAZOLINE
  • 8-BROMO-2,4-DICHLOROQUINAZOLINE
  • Quinazoline, 8-bromo-2,4-dichloro-
  • 8-BROMO-2,4-DICHLOROQUINAZOLINE ISO 9001:2015 REACH
CAS:
331647-05-3
MF:
C8H3BrCl2N2
MW:
277.93
Mol File:
331647-05-3.mol
More
Less

8-BROMO-2,4-DICHLOROQUINAZOLINE Chemical Properties

Boiling point:
330.2±24.0 °C(Predicted)
Density 
1.851
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-1.75±0.30(Predicted)
Appearance
Off-white to light yellow Solid
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
2933599590
More
Less

8-BROMO-2,4-DICHLOROQUINAZOLINE Usage And Synthesis

Application

8-Bromo-2,4-Dichloroquinazoline is a quinazoline derivative, which is mainly used as an intermediate in pharmaceutical and chemical synthesis.

Synthesis

331646-99-2

331647-05-3

8-Bromoquinazoline-2,4(1H,3H)-dione (12.1 g, 50 mmol, 1 eq.) was used as starting material, which was dissolved in phosphorous trichloride (POCl3, 130 mL), followed by the addition of N,N-dimethylformamide (DMF, 0.5 mL) as catalyst. The reaction mixture was stirred at 130 °C for 12 h. After completion of the reaction, the reaction was cooled to room temperature. The reaction mixture was concentrated by rotary evaporator. The concentrated residue was dissolved in ethyl acetate (EA, 100 mL) and quenched by slowly pouring into ice water under vigorous stirring. The organic phase was separated, washed with saturated saline, dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated again. Finally, the target product 8-bromo-2,4-dichloroquinazoline was purified by column chromatography (eluent: petroleum ether/ethyl acetate = 10:1, v/v) as a yellow solid (9.1 g, 60% yield).

References

[1] Organic Letters, 2011, vol. 13, # 4, p. 676 - 679
[2] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 9, p. 941 - 946
[3] Patent: WO2015/27222, 2015, A2. Location in patent: Paragraph 0214
[4] Patent: WO2016/133935, 2016, A1. Location in patent: Paragraph 0287

8-BROMO-2,4-DICHLOROQUINAZOLINESupplier

Shanghai YuYuan Pharmaceutical Co., Ltd. Gold
Tel
13052276172
Email
product@yuyuanpharm.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
ChemFuture PharmaTech (Jiangsu) Ltd
Tel
5108538618
Email
suger.wang@chemfuture.com
Carbott PharmTech Inc.
Tel
0535-6385396
Email
info@carbottpharm.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com